Fusion Antibodies PLC (FAB) — Tangible Net Worth Ratio
Fusion Antibodies PLC (FAB) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets (GBX0.00) from net assets (GBX726.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Fusion Antibodies PLC's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Fusion Antibodies PLC Tangible Net Worth Ratio (2006–2025)
This chart shows how Fusion Antibodies PLC's Tangible Net Worth Ratio has changed across 19 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 100.0%, reflecting net assets of GBX726.00K with intangible assets of GBX0.00 GBX. See Fusion Antibodies PLC (FAB) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Fusion Antibodies PLC (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Fusion Antibodies PLC from 2006 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Fusion Antibodies PLC (FAB) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | GBX669.00K | GBX0.00 | GBX1.32 Million | ▲ +0.0 pp |
| 2024 | 100.0% | GBX1.79 Million | GBX0.00 | GBX2.42 Million | ▲ +0.0 pp |
| 2023 | 100.0% | GBX1.12 Million | GBX0.00 | GBX2.06 Million | ▲ +0.1 pp |
| 2022 | 99.9% | GBX3.68 Million | GBX2.00K | GBX4.92 Million | ▼ 0.0 pp |
| 2021 | 100.0% | GBX4.75 Million | GBX2.00K | GBX5.83 Million | ▲ +0.0 pp |
| 2020 | 99.9% | GBX4.81 Million | GBX4.00K | GBX6.04 Million | ▲ +0.0 pp |
| 2019 | 99.9% | GBX5.35 Million | GBX6.21K | GBX6.24 Million | ▼ -0.1 pp |
| 2018 | 100.0% | GBX6.58 Million | GBX0.00 | GBX7.21 Million | ▲ +0.0 pp |
| 2017 | 100.0% | GBX1.71 Million | GBX0.00 | GBX2.16 Million | ▲ +0.0 pp |
| 2016 | 100.0% | GBX1.46 Million | GBX0.00 | GBX1.87 Million | ▲ +0.0 pp |
| 2015 | 100.0% | GBX169.29K | GBX0.00 | GBX370.96K | ▲ +0.0 pp |
| 2014 | 100.0% | GBX16.32K | GBX0.00 | GBX313.89K | ▲ +0.0 pp |
| 2013 | 100.0% | GBX50.13K | GBX0.00 | GBX303.69K | ▲ +0.0 pp |
| 2011 | 100.0% | GBX323.00K | GBX0.00 | GBX705.00K | ▲ +0.0 pp |
| 2010 | 100.0% | GBX514.00K | GBX0.00 | GBX819.00K | ▲ +0.0 pp |
| 2009 | 100.0% | GBX188.00K | GBX0.00 | GBX821.00K | ▲ +0.0 pp |
| 2008 | 100.0% | GBX655.00K | GBX0.00 | GBX1.12 Million | ▲ +0.0 pp |
| 2007 | 100.0% | GBX608.00K | GBX0.00 | GBX1.05 Million | ▲ +0.0 pp |
| 2006 | 100.0% | GBX204.00K | GBX0.00 | GBX494.00K | — |